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Abstract
The canonical bacteriophage is obligately lytic: the virus infects a bacterium and hijacks cell
functions to produce large numbers of new viruses which burst from the cell. These viruses are
well-studied, but there exist a wide range of coexisting virus lifestyles that are less understood.
Temperate viruses exhibit both a lytic cycle and a latent (lysogenic) cycle, in which viral genomes
are integrated into the bacterial host. Meanwhile, chronic (persistent) viruses use cell functions
to produce more viruses without killing the cell; chronic viruses may also exhibit a latent stage in
addition to the productive stage. Here, we study the ecology of these competing viral strategies.
We demonstrate the conditions under which each strategy is dominant, which aids in control of
human bacterial infections using viruses. We find that low lysogen frequencies provide competitive
advantages for both virus types; however, chronic viruses maximize steady state density by elimi-
nating lysogeny entirely, while temperate viruses exhibit a non-zero ‘sweet spot’ lysogen frequency.
Viral steady state density maximization leads to coexistence of temperate and chronic viruses,
explaining the presence of multiple viral strategies in natural environments.
∗ clifto2@stolaf.edu
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I. INTRODUCTION
All viruses depend upon their hosts for reproduction. Viruses have evolved many strate-
gies to reproduce within bacteria, including the lytic, temperate, and chronic lifestyles within
the bacterial host [1–3]. After infection, lytic viruses replicate within the bacterial host and
transmit by bursting from the cell, killing the host. Temperate viruses have both a lytic
cycle and a latent cycle, in which the viral genetic material is integrated into host genomes;
latent viruses remain dormant in the bacterial genome until induced to replicate [3]. In
chronic infection, productive host cells bud new viruses from the cell without killing the
bacterium [4]. Chronic viruses may also have a latent cycle in which viral genetic material is
incorporated into the bacterium’s genome, and the cell transmits the virus’s genetic material
(provirus) to daughter cells vertically [5]. Comparative genomics among closely related bac-
terial strains has uncovered a plethora of proviruses of both temperate and chronic lifestyles
[6–11].
Viruses of all four lifestyle classes infect many bacteria relevant to human disease treat-
ment, especially immunocompromised patients vulnerable to common bacterial infections.
In particular, patients with cystic fibrosis or serious burns may become infected with the
ubiquitous Pseudomonas aeruginosa, which can lead to patient death within days if un-
successfully treated [12–14]. Because P. aeruginosa is often resistant to multiple antibiotic
treatments [15–17], phage therapy [18, 19] and phage-antibiotic synergistic (PAS) therapy
[20–22] are now being studied to treat bacterial infections. Response to these treatments
depends significantly on the ecology of the bacteria-virus system already present within the
human host [23]; therefore it is critical to understand the environmental and evolutionary
conditions under which each viral strategy is dominant in order to provide effective treat-
ment.
While mathematical models of lytic viruses (e.g., [24, 25]) and temperate viruses (e.g.,
[26]) have been studied extensively, relatively few models of chronic viruses (e.g., [23, 27, 28])
have been examined. To our knowledge, no studies have rigorously analyzed the ecological
interactions among bacteria and all four viral lifestyles: lytic, latent lytic, chronic, and latent
chronic. Several important open questions exist that neither experimental nor modeling
efforts have yet answered in this context:
1. Experiments have found that temperate virus lysogen frequencies tend to be small
(∼1% of infections) [1]. What are the theoretical underpinnings of this phenomenon?
2. Lysogen frequencies for temperate viruses have been well-studied both experimentally
and theoretically [1, 29, 30], but lysogen frequencies for chronic viruses have not been
determined. What is the predicted range of lysogen frequencies for chronic viruses?
3. Bacterial recovery (cure) rates from viral infection have not been quantified either ex-
perimentally or theoretically. Most mathematical models ignore recovery for simplicity
(e.g., [28]). Experimentally, a wide range of recovery rates has been observed; some
proviruses remain viable over evolutionary timescales (implying recovery rates near
zero) [31], and some proviruses are inactivated nearly instantly by CRISPR systems
(implying extremely fast recovery rates) [32]. Can we establish a narrower range of
typical recovery rates?
In this paper we develop a mathematical model of the competition between temperate
and chronic viruses for bacterial hosts, using P. aeruginosa infections within humans as
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FIG. 1. Flowchart of model equations (1-7). Arrows indicate infection by temperate viruses
(orange), infection by chronic viruses (blue), or recovery from infection (black). Infection rates are
denoted ηi, recovery (cure) rates are denoted γi, and lysogen frequencies are denoted fi.
motivation. An analysis of this model yields simple and intuitive answers to the preceding
questions.
II. MODEL
With the goal of understanding competition between two viral strategies, temperate
viruses VT with lytic and latent lytic stages and chronic viruses VC with productive and
latent chronic stages, we develop a simple model of the bacteria-virus ecosystem (see Figure
1 for the model overview). Each virus may infect a single strain of bacteria that is initially
susceptible (S) to both viral types. We assume the total bacterial population N grows
logistically to a carrying capacity K [33]. Susceptible bacteria grow at a rate rS, and
infected bacteria may grow at either faster or slower rates [34].
Temperate viruses infect susceptible bacteria at a rate ηT ; the infected bacteria will
either become latently infected LT with probability fT , or will enter a lytic state IT with
probability 1 − fT . Bacteria in the lytic state produce viruses and burst (with burst size
βT ) at a rate δ. While in the lytic state, the virus hijacks cell functions, and the cell cannot
reproduce [35, 36]. Bacteria in the latent lytic state reproduce at a rate rT . Bacteria do
not move between lytic and latent states unless the system is stressed (e.g., by heat or
sublethal antibiotics); we ignore spontaneous induction because it is a rare occurrence [37–
39]. However, lytic and latent lytic bacteria may recover from infection at rate γI and γT ,
respectively [31, 40].
Similarly, chronic viruses infect susceptible bacteria at a rate ηC , leading to either latent
infection LC with probability fC or productive infection PC with probability 1 − fC [41].
Bacteria in the productive state reproduce at a rate rP and produce viruses at a rate βC
without cell death. While in the latent chronic state, bacteria reproduce at a rate rC .
Unless the system is stressed, bacteria will not switch from latent to productive states, but
productive and latent chronic bacteria may recover at rate γP and γC , respectively [31, 40].
Again, we ignore spontaneous induction due to its rarity [37–39].
Once a bacterium is infected, we assume it will exclude both superinfection by the same
viral type and cross infection by viruses of the other type [42]. Outside the cell, free tem-
perate viruses and free chronic viruses decay naturally at rates µT and µC , respectively
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[43].
The following equations (1-7) are the dynamical systems model that captures the preced-
ing qualitative description. See Table I for variable descriptions and Table II for parameter
descriptions and relevant values.
S˙ = rSS
(
1− N
K
)
︸ ︷︷ ︸
growth
− ηTSVT − ηCSVC︸ ︷︷ ︸
infection
+ γTLT + γIIT + γPPC + γCLC︸ ︷︷ ︸
recovery
(1)
I˙T = ηT (1− fT )SVT︸ ︷︷ ︸
infection
− δIT︸︷︷︸
lysis
− γIIT︸︷︷︸
recovery
(2)
L˙T = rTLT
(
1− N
K
)
︸ ︷︷ ︸
growth
+ ηTfTSVT︸ ︷︷ ︸
infection
− γTLT︸ ︷︷ ︸
recovery
(3)
P˙C = rPPC
(
1− N
K
)
︸ ︷︷ ︸
growth
+ (1− fC)ηCSVC︸ ︷︷ ︸
infection
− γPPC︸ ︷︷ ︸
recovery
(4)
L˙C = rCLC
(
1− N
K
)
︸ ︷︷ ︸
growth
+ fCηCSVC︸ ︷︷ ︸
infection
− γCLC︸ ︷︷ ︸
recovery
(5)
V˙T = βT δIT︸ ︷︷ ︸
burst
− ηTSVT︸ ︷︷ ︸
adsorption
− µTVT︸ ︷︷ ︸
degradation
(6)
V˙C = βCPC︸ ︷︷ ︸
production
− ηCSVC︸ ︷︷ ︸
adsorption
− µCVC︸ ︷︷ ︸
degradation
(7)
TABLE I. Description of model variables in bacteria-virus system (1-7). Due to nondimension-
alization of density and time, all variables and parameters are nondimensional; all densities are
relative to the bacterial carrying capacity and all rates are relative to the growth rate of uninfected
bacteria.
Variable Meaning
S density of susceptible bacteria
IT density of lytic bacteria preparing to burst
LT density of latent lytic bacteria
PC density of productive bacteria
LC density of latent chronic bacteria
N density of all bacteria (S + IT + LT + PC + LC)
VT density of free temperate viruses
VC density of free chronic viruses
t time normalized by bacterial reproduction rate
Note that infection rates for temperate and chronic viruses, although assumed constant,
may depend on the bacterial population; many relevant bacteria form biofilms at high den-
sity that protect the population from infection [53]. For simplicity, we have also assumed
4
TABLE II. Description of model parameters in bacteria-virus system (1-7). Due to nondimension-
alization of density and time, all variables and parameters are nondimensional; all densities are
relative to the bacterial carrying capacity and all rates are relative to the growth rate of uninfected
bacteria.
Parameter Meaning Rangea Baseline Sources
rS net growth rate of susceptible bacteria, normalized
to 1
1b 1 [44]
rT , rP , rC growth rates of (respectively) latent lytic, produc-
tive, and latent chronic bacteria
[0.5, 3]c 1 [34, 45]
K carrying capacity of bacteria, normalized to 1 1 1
ηT , ηC infection rate of (respectively) temperate and
chronic viruses
[0.38, 14.7]d 1 [26]
γT , γP , γC recovery rates of (respectively) latent lytic, produc-
tive, and latent chronic bacteria
[0,1000]e 0.67f [31, 32]
γI recovery rates of lytic bacteria [0,1000] 0
g [31, 32]
δ rate at which lytic infection leads to bursting
(eclipse and rise phase)
[1.5, 7.8]h 4 [46, 47]
fT lysogen frequency for temperate viruses [0, 0.9] 0.01 [1, 29,
30]
fC lysogen frequency for chronic viruses [0, 0.9] 0
f [1, 29,
30]
βT burst size for bacteria infected with VT [10, 1000] 100 [46–52]
βC viral production rate for bacteria infected with VC [5, 200] 20 [23]
µT , µC degradation rate of (respectively) free temperate
viruses and free chronic viruses
[0.9, 3.6]i 1 [43]
aall parameter ranges are taken for the human pathogens P. aeruginosa or E. coli and
their viruses, unless otherwise noted.
bgrowth rate is approximately 5.1e-3 min−1 for P. aeruginosa grown in vitro.
cestimates based on E. coli and M13 phage.
destimates based on E. coli and λ phage.
ea wide range of recovery rates has been found; some proviruses are viable over
evolutionary timescales and some proviruses are inactivated nearly instantly by CRISPR
systems.
festimated from viral steady state density (see Results section).
gselected to be 0 to simplify model analysis; allowing γI = γT produces qualitatively
similar results, so the increased model complexity is not justified.
hlow estimate is for PAXYB1 phage and PAO1 host, high estimate is for PAK P3 phage
and PAO1 host.
ilow estimate is for viruses extracted from Raunefjorden, high estimate is for viruses
extracted from Bergen Harbor (strains unknown).
that lysogen frequencies are constant, but some studies have demonstrated that bacterial
density may impact lysogeny rates [54, 55]. These simplifications are necessary for analytic
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tractability.
III. RESULTS
Although this model is applicable to any bacteria-virus ecosystem with both temperate
and chronic viral lifestyles, we present model predictions using parameters taken from the
human pathogens P. aeruginosa or E. coli and their viruses (see Table II). Besides their
medical relevance, P. aeruginosa and E. coli are among the most well-studied microbes in
science. We initialize the system with S(0) = 1e−3, VT (0) = VC(0) = 1e−7 and all others
zero, following [26]; no bistability exists for our parameter values, so the initial condition
does not affect the steady state (see Supplementary Information). Because we are primarily
interested in recovery from infection that is passed vertically to daughter cells, we take
γI = 0 for the remainder of the paper. The results are qualitatively similar for γI > 0; see
Supplementary Information for full model analysis.
A. Model behavior
In Figure 2, we simulate the model system for the baseline parameter values in Table II.
We see a rapid initial growth of the susceptible population followed quickly by a population
crash caused primarily by lytic infection. Filling the niche created by the susceptible popu-
lation crash are the latent lytic bacteria. After dozens of bacterial divisions, the latent lytic
bacteria recover from infection create a niche for chronically infected bacteria. Eventually,
the chronically infected bacteria become the most abundant in the system because chronic
viruses do not require new susceptible bacteria in order to reproduce.
Although chronically infected bacteria dominate the system, free temperate viruses sta-
bilize at over twice the density of free chronic viruses (Figure 2b). Although little is known
about the proportion of each viral type seen in natural environments, it is known that tem-
perate and chronic viruses frequently coexist [56]. The model predicts that the total virus to
total bacteria ratio stabilizes at 58:1, which falls within the typical range of virus to bacteria
ratios seen in natural environments [57, 58].
The model behaviors presented here use the baselines in Table II. However, the equi-
libria and their respective stability depends on nearly all the model parameters (see the
Supplementary Information for more details).
B. Steady states and stability
While many evolvable parameters (such as viral burst sizes and bacterial growth rates)
are likely limited by physical constraints, lysogen frequency could theoretically take on
any value. Lysogen frequency is of particular interest because latency involves inherent
tradeoffs between vertical and horizontal transmission; the lytic strategy relies on horizontal
transmission only, while the latent strategy uses only vertical transmission.
Therefore, our primary interest for this study is the lysogen frequencies for temperate and
chronic viruses; we look at the possible steady state outcomes for all possible combinations
of lysogen frequencies fT and fC with all other parameters held constant at the baselines
in Table II. Only four stable steady states exist: coexistence (all populations exceed 0),
6
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FIG. 2. Simulation of model equations (1-7). Initial conditions are S(0) = 1e−3, VT (0) = VC(0) =
1e−7 with all others zero. All parameters are held constant at the baseline values given in Table
II. Eventually the temperate and chronic viral strategies reach a stable coexistence state.
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temperate strategy only (VC = PC = LC = 0), chronic strategy only (VT = IT =
LT = 0), and susceptible only (all populations, except S, are 0). See Figure 3 for the
bifurcation diagram.
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FIG. 3. Bifurcation diagram of lysogen frequencies for temperate and chronic viruses. Holding
all other parameters constant at the baseline values given in Table II, we find that four steady
state outcomes are possible: coexistence of both viral strategies, temperate survival with chronic
extinction, chronic survival with temperate extinction, and extinction of both viral strategies (sus-
ceptible bacteria the only survivors). If the lysogen frequency for a particular viral type is too high,
then that virus will not survive. If lysogen frequencies are low enough for both viral types, then
the viruses will coexist. This bifurcation diagram was generated using standard linear stability
analysis; see the Supplementary Information for details on the viral invasion analysis.
Temperate viruses can outcompete chronic viruses if the temperate lysogen frequency is
neither too large nor too small (see ‘Temperate only’ region of Figure 3). If the temperate
lysogen frequency is too high, then chronic viruses will be produced in large numbers rel-
ative to temperate; chronic viruses will infect susceptible bacteria first, eventually driving
temperate viruses to extinction (see ‘Chronic only’ region of Figure 3). If the temperate
lysogen frequency is too low, then temperate viruses lyse bacteria too quickly, leaving room
for productive bacteria to reproduce while the susceptible population also grows; if the
productive bacterial population is large enough (i.e., chronic lysogen frequencies are suffi-
ciently low), then both viral types will coexist (see ‘Coexistence’ region of Figure 3). See
the Supplementary Information for the complete steady state analysis.
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C. Temperate viruses exhibit a ‘sweet spot’ lysogen frequency
Temperate viruses are known to exhibit a small, nonzero lysogen frequency [1, 29, 30, 46–
52]. Our model illustrates why temperate viruses have a theoretical ‘sweet spot’ lysogen
frequency when competing with chronic viruses.
Suppose that temperate viruses select1 a lysogen frequency fT that maximizes steady state
viral abundance, including both free viruses (VT ) and proviruses (LT , as proxy). Because
chronic viruses may also select a lysogen frequency fC that maximizes their viral density,
the optimal lysogen frequency for temperate viruses depends on fC .
Figure 4(a) shows the steady state temperate viral density for all possible combinations of
fT and fC . Given any chronic lysogen frequency fC , temperate viruses may select a lysogen
frequency fT that conditionally maximizes their viral density (optimal strategies are shown
in red). We see that for all possible chronic latency strategies, there exists a small but
nonzero (i.e., sweet spot) lysogen frequency fT that maximizes temperate viral density at
steady state.
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FIG. 4. Viral steady state density over the full range of possible lysogen frequencies (0 ≤ fi ≤ 1) for
temperate and chronic viruses. Color indicates the steady state viral density, and the red line is the
maximum steady state density for each lysogen frequency of the competing virus. (a) Temperate
virus density (VT + LT ) at steady state. The red curve shows the maximum steady state density
for every possible chronic lysogen frequency. Note that the optimal temperate lysogen frequency
jumps from nearly 40% lysogeny to about 1% lysogeny when the chronic lysogen frequency drops
below 20%. This rapid transition occurs because the optimal state for the temperate virus jumps
from a temperate only state to a coexistence steady state. (b) Chronic virus density (VC + LC)
at steady state. The red curve shows that the maximum steady state density for every possible
chronic lysogen frequency is fC = 0. Taking these two steady state density profiles together, it is
evident that chronic viruses should avoid latency (fC = 0), and therefore temperate viruses should
adopt a lysogen frequency near fT = 0.01.
1 We use ‘select’ in the sense of evolutionary game theory.
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D. Chronic viruses should eliminate latency
While lysogen frequencies for temperate viruses are well-studied, lysogen frequencies for
chronic viruses are unknown. Our model reveals that the lysogen frequency for chronic
viruses should be exactly zero. In Figure 4(b), we plot the steady state density of chronic
viruses in the system (VC+LC). For any given temperate viral lysogen frequency fT , chronic
viruses maximize steady state density by selecting a lysogen frequency fC = 0. From an
ecological perspective, this result is intuitive. We have assumed that there is no reproductive
cost to productive infection relative to latent infection, so it benefits chronic viruses to spread
genetic material both horizontally (via production) and vertically (via cell division), rather
than vertically alone.
E. Bacterial recovery rate determinable using viral abundance
We use our conclusion that fC = 0, along with the fact that temperate viruses possess a
lysogen frequency around 1% to deduce the typical bacterial recovery (cure) rates. In the
interest of simplicity, we assume all recovery rates are equal: γ = γT = γP = γC . The
appropriate recovery rates should lead to a maximum temperate virus steady state density
(VT + LT ) for fC = 0 and fT ≈ 0.01, which occurs over only a small range of γ ≈ 0.67; see
Figure 4(a).
A wide range of outcomes is possible if the recovery rate γ is not near 0.67 (see Figure
5), but none include temperate lysogen frequencies near 1% and coexistence of both viral
types, as we see in many natural environments.
For γ ≤ 0.2 (very slow intracellular provirus deactivation), optimal temperate lysogen
frequencies are fT = 0 when chronic viruses select the optimal lysogen frequency of fC = 0
(see Figure 5). However, temperate viruses are effectively driven to extinction under these
conditions, implying that extremely stable proviruses are deleterious to temperate viruses.
Due to the presence of both viral types in many environments, we suspect that intracellular
provirus deactivation is not extremely slow.
For moderately slow intracellular provirus deactivation (0.22 ≤ γ ≤ 0.66), optimal tem-
perate lysogen frequencies exceed 5% (see Figure 5). This result implies that temperate
viruses more resilient to deactivation should also increase latency.
If instead 0.68 ≤ γ ≤ 0.79 (moderately fast intracellular provirus deactivation), then the
optimal temperate lysogen frequency is exactly zero again (see Figure 5). In other words,
for faster recovery rates, all temperate viruses would be obligately lytic. Due to this result,
we speculate that temperate proviruses are more resilient to intracellular deactivation than
obligately lytic viruses.
For γ ≥ 0.8 (very fast intracellular deactivation), lysogen frequencies instantaneously
jump to around fT = 0.5, and chronic viruses are driven to extinction (see Figure 5).
IV. DISCUSSION
A. Recovery rates and lysogen frequencies
In environments where temperate and chronic viruses coexist, bacterial recovery rates
should be near γ = 0.67. If proviruses are slightly more stable, then we would expect
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to see higher lysogen frequencies for temperate viruses. For proviruses that are stable on
evolutionary timescales, we would expect to see chronic viruses dominate. For proviruses
that are slightly less stable, we would expect to see the latency strategy disappear. For
proviruses that are quickly deactivated, we would expect to see temperate viruses dominate
with large lysogen frequencies. This predicted recovery rate is faster than one might expect,
so we hope this study encourages more experimental work on the intracellular deactivation
of proviruses within P. aeruginosa.
B. Limitations
With the goal of keeping the model analytically tractable, we have made simplifying
assumptions that may affect the presented results. First, we have assumed mass action
infection dynamics, but P. aeruginosa-virus infection rates may not be well-approximated
by a mass action process, especially for large bacteria population sizes [59, 60]. More realis-
tically, infection rates may slow as population growth activates quorum-sensing and biofilm
formation [53].
In addition, we have assumed the lytic recovery rate is zero and all other recovery rates
are equal. Although assuming γI = 0 produces qualitatively similar results to γI = γT , it
may not be reasonable to assume that all other recovery rates are equal. Future study is
needed to determine how recovery rates are affected by the infection type.
We have also assumed that both viral types produce super-infection and cross-infection
exclusion proteins that prevent a second infection of any kind. While many viruses that infect
P. aeruginosa produce super-infection exclusion proteins that effectively prevent multiple
infections by the same viral type [61, 62], little is known about cross resistance to viral
infection.
Another simplifying assumption is that lysogen frequencies are constant, but some viruses
are able to detect bacteria population density, which appears to affect the frequency of
lysogeny [54, 55]. If this process applies to P. aeruginosa and its viruses, a more sophisticated
model would incorporate a density-dependent latency probability: fT (N) and fC(N).
Finally, in deducing the expected chronic lysogen frequency fC and the recovery (cure)
rates γ, we have assumed that all other parameters are exactly the baselines given in Table
II. While the literature has provided reasonable ranges for these parameters, several baseline
values (e.g., βC , ηT , and ηC) were simply selected within those ranges. Given the uncertainty
in several parameter values, the model-inferred parameters fC and γ are also uncertain.
C. Future steps
This model could serve as a base for more sophisticated extensions. For instance, the
presented model does not include an evolutionary component and is therefore only appli-
cable on short time scales. However, this model could be part of a multi-scale model that
incorporates both short time-scale (ecological) dynamics and long time-scale (evolutionary)
dynamics.
Also, we have assumed that no environmental stressors (e.g., radiation, heat, sublethal
antibiotics) perturb the system, but antibiotics are often used to treat bacterial infections.
Many classes of antibiotics are known to induce latent proviruses and trigger virus produc-
tion, even if the bacteria are antibiotic resistant [63–67]. In fact, the induction of latent
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viruses is proposed to be one of the mechanisms behind the synergistic effect of antibiotics
and viruses to treat recalcitrant bacterial infections [67, 68]. Infections by P. aeruginosa
represent about 10% of nosocomial infections, are a leading cause of death among patients
with cystic fibrosis, and have been deemed a serious threat on the United States Centers for
Disease Control watch list for antibiotic resistance [15–17]; therefore, a critical next step is
understanding the impact of antibiotic-induced proviruses on control of bacterial infections.
This is the subject of ongoing study.
V. CONCLUSION
We have developed a simple mathematical model of the ecological competition between
temperate and chronic viruses for bacterial hosts. Using the hosts E. coli and P. aeruginosa
as motivation, we demonstrate that low lysogen frequencies provide competitive advantages
for both viral types. Interestingly, chronic viruses theoretically maximize their steady state
density by eliminating latency entirely, but temperate viruses exhibit a non-zero ‘sweet
spot’ lysogen frequency. Using experimental evidence that temperate viruses possess lysogen
frequencies around 1% and that both viral types coexist in real environments, we are able
to estimate the recovery (cure) rates for bacteria. Better understanding of this system
may contribute to optimal treatment of bacterial infections using phage therapy and/or
antibiotics.
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S1. SUPPLEMENTARY INFORMATION
A. Steady states
The following biologically relevant steady-states exist for system (1-7).
• First, it can be readily seen that the trivial steady state, where all population densities are zero,
exists.
• Second, the steady state where only the susceptible class persists and is equal to the bacterial carrying
capacity, S = K, also exists for all parameter values.
• The steady state where only the temperate phage persists, namely PC = VC = LC = 0, also exists.
In this case it holds:
S =
µT
ηT
δ + γI
βT δ(1− fT )− (δ + γI)
VT =
βT δ(1− fT )− (δ + γI)
µT (1− fT ) IT
IT =
rSS(K − S)(1− fT )
(rSS − γIK)(1− fT ) + (δ + γI)K +
(1− fT )(γTK − rSS)
(rSS − γIK)(1− fT ) + (δ + γI)KLT
rT ((γT − γI)(1− fT ) + δ + γI)L2T + (γT (1− fT )(rSS + δK) + (δ + γI)rSfTS − (δ + fT γI)rT (K − S))LT−
fT (δ + γI)rSS(K − S) = 0
• Similarly, when only the chronic phage persists, namely when IT = VT = LT = 0, it holds
S =
µC
ηC
γP
βC(1− fC)− γP
PC =
K − S
1 + fCγP(1−fC)γC
LC =
fCγP
(1− fC)γC PC
VC =
βC(1− fC)− γP
µC(1− fC) PC
• Finally, if all population densities are positive, it holds
S =
µT
ηT
δ + γI
βT δ(1− fT )− (δ + γI)
1− N
K
=
γP
rP
− (1− fC)βC
rP
ηCS
ηCS + µC
VT =
βT δ(1− fT )− (δ + γI)
µT (1− fT ) IT
VC =
βC
ηCS + µC
PC
LT =
fT
1− fT
δ + γI
γT − rT
(
1− NK
)IT
LC =
ηCfCβCS
ηCS + µC
1
γC − rC
(
1− NK
)PC .
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The following linear 2× 2 system can be solved to yield a unique steady-state.(
δ + γI
1− fT
γT (1− fT )− rT
(
1− NK
)
γT − rT
(
1− NK
) − γI) IT +( ηCβCS
ηCS + µC
γC(1− fC)− rC
(
1− NK
)
γC − rC
(
1− NK
) − γP)PC =
rSS
(
1− N
K
)
(
1 +
fT
1− fT
δ + γI
γT − rT
(
1− NK
)) IT +(1 + ηCfCβCS
ηCS + µC
1
γC − rC
(
1− NK
))PC = N − S
B. Viral invasion fitness
The basic reproductive number R0, traditionally defined as the average number of new infections gener-
ated by an infectious individual in an entirely susceptible population [69], has long been used to characterize
a pathogen’s fitness [28, 70–72]. The basic reproductive number has been found to be correlated with the
between-host transmission rate [73], the number of free infective propagules produced per infected host
(virions, in our case), and life-history traits such as mortality, fecundity, and growth [70, 74].
In this study, R0 is used to determine the growth rate of a viral invader in a population of residents
at steady state. Specifically, when either the temperate or chronic virus attempts to invade the bacterial
population, the virus is successful when its respective R0 is greater than one. Similarly, when one of the
two viruses is the resident, the other virus can invade and coexist as long as its R0 is greater than one. The
various regions where each virus invades and persists are shown in Figure 3.
One of the goals and challenges of phage therapy is to ensure that there is active viral replication [25].
This occurs when, after an initial dose of the virus, it is able to proliferate in its bacterial host. There are
cases however, when viral replication does not take place, so repeated administration of the virus is required.
There already exist various models that study viral kinetics and provide thresholds that guarantee active
replication of lytic-only viruses [25, 75]. Yet, as in most models, recovery of the bacterial host is neglected.
Given the large range of recovery rates that viruses exhibit [31, 32], in this work, we investigate and
identify viral recovery strategies that optimize viral abundance. Although the basic reproductive number
is a traditional measure of fitness (see e.g., [76]), using abundance as a proxy for competitive advantage is
also common (see e.g., [77]).
C. Linear stability analysis and bifurcations
1. The trivial equilibrium is linearly unstable for all choices of parameter values.
2. The steady-state with S = K is linearly stable as long as
RT =
(1− fT )ηTβT δK
(µT + ηTK)(δ + γI)
< 1, RC =
(1− fC)ηCβCK
γP (µC + ηCK)
< 1.
We notice from the previous section that when S = K it holds
S =
µT
ηT
δ + γI
βT δ(1− fT )− (δ + γI) = K ⇔ RT = 1
and
S =
µC
ηC
γP
βC(1− fC)− γP = K ⇔ RC = 1.
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Therefore, the bacterium only (S = K) steady-state undergoes a transcritical bifurcation with the
PC = VC = LC = 0 (temperate only) steady state when RT = 1. Similarly, it undergoes a transcritical
bifurcation with the IT = VT = LT = 0 (chronic only) steady state when RC = 1.
3. The temperate only steady state undergoes a transcritical bifurcation with the coexistence steady
state when
RTC =
(1− fC)βCηCS
ηCS + µC
1
γP − rP
(
1− NK
) = 1, where S = µT
ηT
δ + γI
βT δ(1− fT )− (δ + γI) ,
and N = S + IT + LT .
4. There is a transcritical bifurcation from the chronic only to the coexistence steady-state when
RCT =
(1− fT )βT δηTS
(ηTS + µT )(δ + γI)
= 1, where S =
µC
ηC
γP
βC(1− fC)− γP .
All these bifurcations are obtained by a standard linear stability analysis around the relevant steady states.
D. Model non-dimensionalization
The model system (1-7) can be non-dimensionalized so that time and bacterial density are unitless
quantities. We will illustrate with equation (1) with γI = 0, but the methodology is analogous for all other
equations in the system. Suppose the system (1-7) has bacterial density units of CFU/mL and time units
of minutes. Then equation (1) has units CFU/mL/min:
dS
dt
= rSS
(
1− N
K
)
︸ ︷︷ ︸
growth
− ηTSVT − ηCSVC︸ ︷︷ ︸
infection
+ γTLT + γPPC + γCLC︸ ︷︷ ︸
recovery
.
We will divide the entire equation by rSK, i.e. the bacterial growth rate (in min
−1) multiplied by the
carrying capacity (in CFU/mL):
d(S/K)
d(rSt)
=
S
K
(
1− N
K
)
︸ ︷︷ ︸
growth
− ηT
rS
S
K
VT − ηC
rS
S
K
VC︸ ︷︷ ︸
infection
+
γT
rS
LT
K
+
γP
rS
PC
K
+
γC
rS
LC
K︸ ︷︷ ︸
recovery
.
Now S˜ = S/K is a unitless bacterial density, t˜ = rSt is a unitless time, η˜i = ηi/rS is an infection rate
per PFU/mL, and γ˜i = γi/rS is a unitless recovery rate:
dS˜
dt˜
= S˜
(
1− N˜
)
︸ ︷︷ ︸
growth
− η˜T S˜VT − η˜C S˜VC︸ ︷︷ ︸
infection
+ γ˜T L˜T + γ˜P P˜C + γ˜CL˜C︸ ︷︷ ︸
recovery
.
For the sake of clarity, we have suppressed tilde notation throughout the main manuscript. The same
effect is achieved by choosing γ = 1 and K = 1 in system (1-7) and reinterpreting bacterial populations
as fractions of the carrying capacity and rates (except infection and adsorption) as multiples of the growth
rate. All parameters in Table II have been scaled as such (details follow).
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E. Parameter selection
The growth rate rS for P. aeruginosa in vitro is approximately 5.1e-3 min
−1 [44], although P. aerugi-
nosa growth is highly variable in humans [45]. Therefore all rate parameters provided in min−1 are scaled
by this rate in order to non-dimensionalize.
The carrying capacity K of bacteria in a medium depends on the environment. Even within the
sputum of patients with cystic fibrosis, the carrying capacity is difficult to estimate due to variability among
patients. One study of patients with cystic fibrosis found that the densities of viable P. aeruginosa in
sputum of 12 patients not undergoing treatment ranged from 5.3e3 CFU/mL to 1.8e11 CFU/mL [78].
The infection rate for E. coli and T4 phage in mucus (assuming mass action infection) is known to be
approximately 47e-10 mL/min per CFU per PFU [79, 80]. Infection in marine ecosystems (also assuming
mass action infection) is similar at around 24e-10 mL/min per CFU per PFU [77, 79]. Given our uncertainty
in the bacterial carrying capacity, we elected to use an infection rate within the range given by Sinha et al.
[26]; the authors fit their mass action infection model to time series population data that reached carrying
capacity. The authors presented Kη ∈ [0.45, 100] hr−1 and rS ∈ [0.5, 10] hr−1. Non-dimensionalization leads
to a range of η between 0.045 and 200, and our selected value of η = 1 is near the geometric mean of that
range.
The phage production delay rate δ is estimated based on the eclipse and rise phase of PAXYB1 and
PAK P3 phage [46, 47]. The eclipse (latent) and rise phase is 130 minutes total for PAXYB1 [46] and 27
minutes total for PAK P3 [47]. The smallest (non-dimensional) delay rate is then 1/130/5.1e-3= 1.5, and
the largest is 1/27/5.1e-3= 7.3. We selected the approximate average of this range, 4, to be the delay rate.
The phage degradation rate µi is estimated based on the decay rates of phage in aquatic environments
[43]. The decay rates ranged from 0.26 to 1.1 per hour. We non-dimensionalize by multiplying by 60 minutes
per hour and the bacterial growth rate, 5.1e-3 per minute. The non-dimensional range of decay rates is then
0.9 to 3.6. We selected a value of 1 arbitrarily from this range.
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FIG. 5. Viral steady state density over the full range of possible lysogen frequencies (fi ∈ [0, 1]) for
temperate and chronic viruses. Color indicates the steady state viral density, and the red line is
the maximum steady state density for each lysogen frequency of the competing virus. Left panel is
temperate virus density (VT +LT ) at steady state. Right panel is chronic virus density (VC +LC)
at steady state. Top row is γ = 0.2, followed by γ = 0.66, γ = 0.68, and the bottom row is γ = 1.
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